Trial Profile
A Multicenter Open-labeled Pilot Study on Recombinant Human Thrombopoietin in Management of Immune Thrombocytopenia in Pregnancy
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 21 Sep 2023
Price :
$35
*
At a glance
- Drugs Thrombopoietin (Primary)
- Indications Idiopathic thrombocytopenic purpura
- Focus Adverse reactions; Therapeutic Use
- 19 Mar 2020 Status changed from recruiting to completed.
- 06 Dec 2016 Results assessing efficacy and safety presented at the 58th Annual Meeting and Exposition of the American Society of Hematology.
- 18 Apr 2016 Planned End Date changed from 1 Jun 2017 to 1 Dec 2017.